mallinckrodt.comMallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company | Mallinckrodt Pharmaceutic
mallinckrodt.com Profile
mallinckrodt.com
Sub Domains:remoteuser.mallinckrodt.com
Title:Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company | Mallinckrodt Pharmaceutic
Description:As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more.
Discover mallinckrodt.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
mallinckrodt.com Information
Website / Domain: |
mallinckrodt.com |
HomePage size: | 47.817 KB |
Page Load Time: | 0.778774 Seconds |
Website IP Address: |
146.214.96.202 |
Isp Server: |
Tyco Healthcare - Mallinckrodt |
mallinckrodt.com Ip Information
Ip Country: |
United States |
City Name: |
Hazelwood |
Latitude: |
38.777446746826 |
Longitude: |
-90.37353515625 |
mallinckrodt.com Keywords accounting
mallinckrodt.com Httpheader
Cache-Control: private |
Content-Type: text/html; charset=utf-8 |
Server: Microsoft-IIS/10.0 |
Set-Cookie: ASP.NET_SessionId=va4u0tzgwgddfyofkdug32re; path=/; HttpOnly, BIGipServerEPI_Web_Farm_Pool_80=1589958290.20480.0000; path=/; Httponly |
X-AspNetMvc-Version: 5.2 |
X-AspNet-Version: 4.0.30319 |
X-Powered-By: ASP.NET |
Date: Sun, 19 Jul 2020 22:26:01 GMT |
Content-Length: 51992 |
mallinckrodt.com Meta Info
charset="utf-8"/ |
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
content="As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more." name="description"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="#191919" name="theme-color"/ |
content="website" property="og:type" |
content="Mallinckrodt" property="og:site_name" |
content="http://www.mallinckrodt.com/" property="og:url" |
content="Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company | Mallinckrodt Pharmaceuticals" property="og:title" |
content="As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more." property="og:description" |
content="https://www.mallinckrodt.com/globalassets/images/logo-header.png" property="og:image"/ |
146.214.96.202 Domains
mallinckrodt.com Similar Website
Domain |
WebSite Title |
mallinckrodt.com | Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company | Mallinckrodt Pharmaceutic |
citiuspharma.com | Citius Pharmaceuticals – A Specialty Pharmaceutical Company |
endo.com | Endo | A Global Specialty Pharmaceutical Company |
medpharma.pharmaceuticalconferences.com | Med Pharma Congress 2020 | Pharmaceutical Events | Medicinal Conferences | Pharmaceutical Conference |
mobile.in-pharmatechnologist.com | Pharmaceutical news, Pharma industry, Pharmaceutical manufacturing |
in-pharmatechnologist.com | Pharmaceutical news, Pharma industry, Pharmaceutical manufacturing |
remoteuser.mallinckrodt.com | Log On - Mallinckrodt |
research.pharmaceuticalconferences.com | Pharma Conferences | Pharmaceutical Research Conferences 2020| Pharmaceutical Sciences Meetings: Bi |
qww.ispe.org | Pharmaceutical Engineering Home | ISPE | International Society for Pharmaceutical Engineering |
wwww.ispe.org | Pharmaceutical Engineering Home | ISPE | International Society for Pharmaceutical Engineering |
pharmaceuticalchemistry.pharmaceuticalconferences.com | Pharmaceutical chemistry conferences|Pharmaceutical Chemistry Congress | Pharmaceutical Conferences |
dcisolution.com | DCI Solution | Specialty Valuations, Specialty Vehicles, Special Service |
intrinsiq.com | IntrinsiQ Specialty Solutions | Technology and data insights for specialty practices |
amberpharmacy.com | Amber Specialty Pharmacy | Specialty Drugs & Medications |
industry.pharmaceuticalconferences.com | Top Pharma Conferences 2020 | Pharma Conference 2020 | Pharmaceutical Conferences | Pharmaceutical S |
mallinckrodt.com Traffic Sources Chart
mallinckrodt.com Alexa Rank History Chart
mallinckrodt.com Html To Plain Text
Search Font Size About Us About Us Executive Committee Mark Trudeau Mark Casey Hugh O’Neill Bryan Reasons Steven Romano, M.D. Ian Watkins Select Senior Leaders Spiro Gavaris Tunde Otulana, M.D. Michele Robertson Brandi Robinson Kathleen Schaefer Daniel Speciale Board of Directors Angus Russell Mark Trudeau David Carlucci J. Martin Carroll Paul R. Carter David Norton Carlos V. Paya, M.D., Ph.D. JoAnn Reed Anne C. Whitaker Kneeland Youngblood, M.D. Scientific Advisory Council COVID-19 Blog Core Strengths Facts About Acthar Gel Inclusion & Diversity MNK Recent Acquisitions Our Story Partnering Suppliers Patient Stories 150th Anniversary Products Research Research Science & Technology Pipeline Research & Development Clinical Trials Formulation & Drug Delivery Technologies Medical Affairs Ongoing Investigator-Initiated Studies Research & Educational Grants Responsibility Responsibility Community Outreach Mallinckrodt Community Giving Philanthropy Contacts Corporate Compliance Corporate Transparency Expanded Access Program for Investigational Products Interactions with Health Care Professionals Pledge on Drug Pricing & Innovation Quality, Environment, Health & Safety Responsible Use Healthcare Issues Programs Red Flags Medication Disposal COVID-19 Hand Sanitizer Donations Sustainability Investor Relations Investor Relations Analyst Coverage Annual Reports Calendar of Events Corporate Governance Historical Data on Acquired Companies Information Request Presentation Documents SEC Filings Supplemental Financial Information Contact Us News & Media Careers Careers Who We Are What We Do Our Values & People Where We Are Search All Opportunities Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies settings, please read our Privacy Policy . By continuing to browse the site, you are agreeing to accept our use of cookies. I Agree SEEING COMPLEXITY IN A NEW LIGHT Where others see complexity, we see value for patients and shareholders SEEING VALUE FOR PATIENTS Where others see complexity, we see healthier lives SEEING OPPORTUNITY FOR SHAREHOLDERS Where others see complexity, we see potential for growth Managing Complexity. Improving Lives. For more than 150 years, Mallinckrodt has been advancing the fields of science and medicine to improve the lives of people around the world. About Us Bold Path. Brighter Future. Grow your career, and become part of our legacy as we make a lasting difference in the lives of patients. Careers A Diverse and Growing Pipeline. Mallinckrodt is focused on developing innovative therapies and cutting-edge technologies for patients with severe and critical conditions and has products spanning all phases of clinical development. Pipeline Managing Complexity. Improving Lives. News & Media Mallinckrodt Announces U.S. Food and Drug Administration (FDA) Advisory Committee Voted to Recommend Terlipressin for Approval to Treat Patients with Hepatorenal Syndrome Type 1 (HRS-1) Mallinckrodt and Terumo BCT Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Treatment of Cutaneous T-Cell Lymphoma (CTCL) in Adults Mallinckrodt to Report Earnings Results for Second Quarter 2020 COVID-19 Resources We are so grateful for all first responders, healthcare professionals and essential employees' efforts in the battle against COVID-19. We believe in listening to needs and delivering solutions and we are proud to join you in the fight. We are doing a variety of things to make a difference. Learn More Corporate Social Responsibility Report Mallinckrodt releases its first annual Corporate Social Responsibility report that illustrates a wide-ranging commitment to corporate stewardship. Read More A Diverse and Growing Pipeline Mallinckrodt is focused on developing innovative therapies and cutting-edge technologies for patients with severe and critical conditions and has products spanning all phases of clinical development. View Our Pipeline Agreement in Principle for Global Opioid Settlement Mallinckrodt Announces Agreement in Principle for Global Opioid Settlement and Associated Debt Refinancing Activities Read More Prescription Drug Abuse Prevention Mallinckrodt supports a broad range of programs that encourage the appropriate prescribing, use, storage and disposal of pain medications. Learn More Mallinckrodt's Pledge on Drug Pricing and Innovation We pledge to create the best possible healthcare at the lowest possible cost for the greatest number of people. Our Pledge Our Products Building on our heritage and distinctive capabilities, our world-class development and formulation expertise bring medical solutions to the marketplace. Get Product Information NYSE: MNK as of July 17 2020 4:10 PM (ET) $ 2.86 -0.01 / -.35% Local time: 05:26:01 PM Open: $2.89 High: $2.98 Low: $2.79 Volume: 2708330 Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Resources For: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure...
mallinckrodt.com Whois
"domain_name": [
"MALLINCKRODT.COM",
"mallinckrodt.com"
],
"registrar": "CSC CORPORATE DOMAINS, INC.",
"whois_server": "whois.corporatedomains.com",
"referral_url": null,
"updated_date": [
"2019-09-05 05:24:33",
"2019-09-05 01:24:33"
],
"creation_date": [
"1996-09-10 04:00:00",
"1996-09-10 00:00:00"
],
"expiration_date": "2020-09-09 04:00:00",
"name_servers": [
"NS1.MNK.COM",
"NS2.MNK.COM",
"ns1.mnk.com",
"ns2.mnk.com"
],
"status": [
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited",
"serverTransferProhibited https://icann.org/epp#serverTransferProhibited",
"serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited",
"clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited",
"serverDeleteProhibited http://www.icann.org/epp#serverDeleteProhibited",
"serverTransferProhibited http://www.icann.org/epp#serverTransferProhibited",
"serverUpdateProhibited http://www.icann.org/epp#serverUpdateProhibited"
],
"emails": [
"domainabuse@cscglobal.com",
"mkgwebsupport@mallinckrodt.com"
],
"dnssec": "unsigned",
"name": "MALLINCKRODT LLC",
"org": "Mallinckrodt LLC",
"address": null,
"city": "Hazelwood",
"state": "MO",
"zipcode": "63042-2301",
"country": "US"